# BioNexus Gene Lab Corp. (BGLC)

> Industrials · MY · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BGLC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 99.0K | $ -830.0K | $ -591.8K | $ 198.6K | $ 7.78M |
| 2025 | $ 7.60M | $ -3.06M | $ -1.92M | $ 176.0K | $ 8.61M |
| 2024 | $ 10.00M | $ -1.68M | $ -2.54M | $ 210.6K | $ 8.32M |
| 2023 | $ 10.56M | $ -2.84M | $ -1.57M | $ 146.6K | $ 9.66M |
| 2022 | $ 12.21M | $ -397.7K | $ 562.7K | $ 56.8K | $ 6.67M |
| 2021 | $ 15.88M | $ 893.4K | $ 7.1K | $ 76.9K | $ 7.18M |
| 2020 | $ 23.73M | $ 3.23M | $ -111.9K | $ 123.4K | $ 6.66M |
| 2019 | $ 163.9K | $ -318.1K | $ -297.0K | $ 89.4K | $ 1.12M |
| 2018 | $ 280.4K | $ 106.3K | $ -414.3K | $ 82.1K | $ 1.52M |
| 2017 | $ 86.9K | $ -88.0K | $ 98.9K | $ 0 | $ 94.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 6.08 |

## Other views

- [Metrics](https://sponda.capital/en/BGLC.md)
- [Charts](https://sponda.capital/en/BGLC/charts.md)
- [Compare](https://sponda.capital/en/BGLC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.